维普中文期刊产品整合服务
12篇 您的检索式:作者名="Portera CC"
    题名 作者 年代 出处 被引量
1Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer显示文摘Portera CC Walshe JM Rosing DR 2008Clin Cancer Res2008,14,9:1
2Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer显示文摘Portera CC Walshe JM Rosing DR 2008Clin Cancer Res2008,14,9:1
3Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients withhuman epidermal growth factor receptor 2-positive metastatic breast cancer显示文摘Portera CC Walshe JM Rosing DR 2008Clin Cancer Res2008,14,9:1
4Evaluation of Lymphangiogenic Factors,Vascular Endothelial Growth Factor D and E-Cadherin in Distinguishing Inflammatory from Locally Advanced Breast Cancer显示文摘Levine PH Portera CC Hoffman HJ 0,,:1
5Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with 显示文摘Portera CC Walshe JM Rosing DR 2008Clin Cancer Res2008,14,9:1
6Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with trastuzumab-insensitive human epidermal growth factor receptor 2-positive metastatic breast cancer显示文摘Portera CC Walshe JM Rosing DR 2008Clin Cancer Res2008,14,9:1
7Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with[corrected]human epidermal growth factor receptor 2-positive metastatic breast cancer显示文摘Portera CC Walshe JM Rosing DR 0,,09:1
8Cardiac toxicity and efficacy of trastuzumab combined with per- tuzumab in patients with trastuzumab-lnsensitive hu- man epidermal growth factor receptor 2-positive meta- static breast cancer显示文摘Portera CC Walshe JM Rosing DR 2008Clin Cancer Res2008,14,9:1
9Evaluation oflymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer显示文摘Levine PH Portera CC Hoffman H J 2012Clin Breast Cancer2012,12,4:1
10Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cance显示文摘Portera CC Walshe JM Rosing DR et ' tl 2008Clin Cancer Res2008,14,9:1
11Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with corrected human epidermal growth factor receptor 2-positive metastatic breast cancer显示文摘Portera CC Walshe JM Rosing DR 2008Clin Cancer Res2008,14,9:1
12Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer显示文摘Portera CC Walshe JM Rosing DR 2008Clin Cancer Res2008,14,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费